Inventor

Kartik M. Keertikar

Inventor
East Windsor, NJ, US

Overview

19→
Patents
2006–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds34%
A61KPreparations for medical, dental or toiletry purposes21%
Y02PClimate change mitigation technologies in the production or processing of goods4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
10,646,494Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases202010,138,255Piperazine derivatives as HIV protease inhibitors20189,840,478'Piperazine derivatives as HIV protease inhibitors'20178,673,924'Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors'20148,609,635'Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases'20138,609,676'4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors'20138,586,576'Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors'20138,580,782'Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors'20138,318,735'2-aminothiazole-4-carboxylic amides as protein kinase inhibitors'20128,076,479'Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro-pyrazolo[1,5-a]pyrimidin-7-yl)-amino derivatives and intermediates'20117,807,683'N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors'20107,605,155'Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors'20097,452,902'Imidazopyridines as cyclin dependent kinase inhibitors'20087,342,016'Farnesyl protein transferase inhibitors as antitumor agents'20087,196,078'Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors'20077,161,003'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'20077,151,104'Pyrazolopyridines as cyclin dependent kinase inhibitors'20067,119,200'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'20066,992,080'Imidazopyridines as cyclin dependent kinase inhibitors'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2011Patents assigned to SCHERING CORP (7)· patent assignee history
2006–2020Based in East Windsor, NJ, US· patent location history
2011–2014Patents assigned to KEERTIKAR KARTIK M (7)· patent assignee history
2012–2020Patents assigned to MERCK SHARP & DOHME (9)· patent assignee history
2012–2014Patents assigned to DWYER MICHAEL P (4)· patent assignee history
2012–2014Patents assigned to GUZI TIMOTHY J (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SHARP & DOHME92012–2020
KEERTIKAR KARTIK Mself72011–2014
SCHERING CORP72006–2011
DWYER MICHAEL P42012–2014
GUZI TIMOTHY J42012–2014
Locations
LocationPatentsSpan
East Windsor, New Jersey, US192006–2020